13D/13G Filings - SUTRO BIOPHARMA INC. (STRO)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-12
4:10 pm
Purchase
2020-12-31 13G Sutro Biopharma, Inc.
STRO
EVENTIDE ASSET MANAGEMENT LLC 2,370,975
5.300%
1,126,080increase
(+90.46%)
Filing
History
2021-02-02
3:13 pm
Purchase
2020-12-31 13G Sutro Biopharma, Inc.
STRO
BlackRock Inc.
BLK
2,717,929
6.200%
2,717,929increase
(New Position)
Filing
History
2020-08-28
4:06 pm
Purchase
2020-08-19 13G Sutro Biopharma, Inc.
STRO
EcoR1 Capital LLC 2,328,492
6.500%
2,328,492increase
(New Position)
Filing
History
2020-08-24
6:54 pm
Purchase
2020-08-13 13G Sutro Biopharma, Inc.
STRO
Ridgeback Capital Investments L.P. 2,014,687
5.300%
2,014,687increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2